New and future therapies: Changes in the therapeutic armamentarium for SLE. (PubMed, Best Pract Res Clin Rheumatol) - Aug 27, 2023 - "Anifrolumab, the anti-interferon medication, to treat non-renal lupus; voclosporin, a calcineurin inhibitor, for the treatment of lupus nephritis; and belimumab for lupus nephritis. The therapeutic management and prognosis of SLE have profoundly evolved with changes in the therapeutic armamentarium. With the broad pipeline of targeted treatments in clinical development and new treatment strategies in the future, current challenges are transitioning from the availability of new drugs to the selection of the most appropriate strategy at the patient level."
Journal • Review • Bone Marrow Transplantation • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus • Transplantation
|
|
Anca Askanase; Eden Sebbag; François Chasset; Laurent Arnaud; Leila Khalili; Marc Scherlinger; Philippe Mertz; Renaud Felten; Wei Tang
|